Grants and Contributions:
Title:
Generation of Chicken Monoclonal Antibodies using Recombinant DNA Technology
Agreement Number:
885833
Agreement Value:
$304,637.00
Agreement Date:
May 15, 2017 - Apr 30, 2019
Description:
The Firm intends to develop and validate a novel recombinant antibody discovery platform using a chicken immune system. This platform will allow scientists to reach into unexplored regions of protein targets (i.e. novel epitopes) by exploiting the benefits of employing a species that is phylogenetically distant from humans, thereby providing access to previously unavailable epitopes. These antibodies can be utilized for research, diagnostics and therapeutics processes.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Charlottetown, Prince Edward Island, CA C1E 0B7
Reference Number:
172-2018-2019-Q1-885833
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
806733887
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 120 days. The total amended value is 66,885 dollars.
Amendment Date
Jan 2, 2019
Recipient's Legal Name:
Somru BioScience Inc.
Federal Riding Name:
Charlottetown
Federal Riding Number:
11002
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: